ArticleDiabetology & metabolic syndrome2017
Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus.
Shusuke Yagi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
92 papers cite itlatest 60 shown
this paperpooled ittrialcites it